AI & Machine Learning

The move to categorize cardiovascular machine learning software under regulation 21 CFR 870.2380 creates a new benchmark for medical technology safety. This initiative by the U.S. Food and Drug Administration clarifies the expectations for how digital tools are developed, validated, and brought to

The ability to reconstruct the history of our species using ancestral recombination graphs has exposed genetic depths that were previously invisible to traditional fossil analysis. This methodology allows researchers to look beyond the physical remains of our ancestors, revealing a complex tapestry

Strategic use of digital shadows allows engineers to run what-if simulations without risking the integrity of a physical production batch during development. This capability marks a dramatic departure from the era when biological manufacturing was as much an art form as it was a science. In the

The politicization of daily life during biological emergencies makes the governance of information as critical to safety as the distribution of essential medical supplies. In the contemporary landscape of 2026, the success of any public health intervention is no longer measured solely by laboratory

The current pharmaceutical landscape is witnessing a profound transformation as the successful clinical implementation of personalized mRNA cancer vaccines begins to redefine the standard of care in oncology. This seismic shift is driven by a long-held vision: the ability to train a patient’s own

Synthetic DNA companies frequently ship genetic sequences without a federal requirement to screen orders for dangerous pathogens, leaving a critical pipeline open for exploitation. This alarming reality is a central focus of the recent findings released by Anthropic, which have sent ripples through